ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE: 1,702 Adverse Event Reports & Safety Profile
Thyroid Balance & Feminine Wellness
Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.
1,702
Total FAERS Reports
22 (1.3%)
Deaths Reported
122
Hospitalizations
1,702
As Primary/Secondary Suspect
12
Life-Threatening
26
Disabilities
Active Ingredient: ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE ACETATE ·
First Report: 19700101 · Latest Report: 20250801
What Are the Most Common ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Side Effects?
#1 Most Reported
Drug ineffective
178 reports (10.5%)
#2 Most Reported
Hot flush
156 reports (9.2%)
#3 Most Reported
Malaise
135 reports (7.9%)
All ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 178 | 10.5% | 0 | 10 |
| Hot flush | 156 | 9.2% | 0 | 6 |
| Malaise | 135 | 7.9% | 0 | 26 |
| Feeling abnormal | 123 | 7.2% | 1 | 14 |
| Insomnia | 121 | 7.1% | 0 | 10 |
| Off label use | 119 | 7.0% | 1 | 6 |
| Intentional product misuse | 95 | 5.6% | 1 | 9 |
| Product prescribing error | 84 | 4.9% | 0 | 9 |
| Vaginal haemorrhage | 77 | 4.5% | 0 | 4 |
| Headache | 72 | 4.2% | 0 | 9 |
| Pain | 63 | 3.7% | 0 | 11 |
| Anxiety | 62 | 3.6% | 0 | 8 |
| Depression | 61 | 3.6% | 1 | 7 |
| Hyperhidrosis | 61 | 3.6% | 0 | 7 |
| Fatigue | 55 | 3.2% | 0 | 8 |
| Night sweats | 55 | 3.2% | 0 | 1 |
| Weight increased | 51 | 3.0% | 0 | 4 |
| Therapeutic response unexpected | 50 | 2.9% | 0 | 6 |
| Alopecia | 47 | 2.8% | 0 | 4 |
| Illness | 47 | 2.8% | 0 | 6 |
Who Reports ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Side Effects? Age & Gender Data
Gender: 99.9% female, 0.1% male. Average age: 62.7 years. Most reports from: US. View detailed demographics →
Is ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 4 | 0 | 0 |
| 2001 | 1 | 0 | 0 |
| 2002 | 2 | 0 | 0 |
| 2003 | 5 | 0 | 1 |
| 2005 | 3 | 0 | 1 |
| 2006 | 3 | 1 | 0 |
| 2007 | 5 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 5 | 0 | 2 |
| 2011 | 4 | 0 | 3 |
| 2012 | 10 | 2 | 4 |
| 2013 | 20 | 0 | 6 |
| 2014 | 53 | 0 | 9 |
| 2015 | 50 | 1 | 8 |
| 2016 | 50 | 0 | 8 |
| 2017 | 38 | 0 | 6 |
| 2018 | 43 | 0 | 6 |
| 2019 | 42 | 0 | 7 |
| 2020 | 47 | 1 | 5 |
| 2021 | 29 | 0 | 4 |
| 2022 | 27 | 1 | 4 |
| 2023 | 21 | 0 | 4 |
| 2024 | 18 | 0 | 2 |
| 2025 | 7 | 0 | 0 |
What Is ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Used For?
| Indication | Reports |
|---|---|
| Hot flush | 272 |
| Menopause | 220 |
| Menopausal symptoms | 197 |
| Hormone replacement therapy | 149 |
| Night sweats | 45 |
| Osteoporosis | 29 |
| Product used for unknown indication | 27 |
| Hormone therapy | 25 |
| Hyperhidrosis | 23 |
| Vulvovaginal dryness | 22 |
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs Alternatives: Which Is Safer?
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ESTROGENS, ESTERIFIED
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ESZOPICLONE
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETANERCEPT
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETANERCEPT-SZZS
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETELCALCETIDE
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETEPLIRSEN
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETESEVIMAB
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETHACRYNIC ACID
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETHAMBUTOL
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
Official FDA Label for ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE
Official prescribing information from the FDA-approved drug label.